Septic arthritis is a severe, time-critical medical and surgical emergency involving microbial invasion of a native or prosthetic joint space1,3. Because the synovial membrane lacks a basement membrane, circulating blood-borne pathogens easily localize within the richly vascularized synovium, rapidly triggering an intense local inflammatory cascade. The resulting influx of neutrophils and release of destructive proteolytic enzymes can cause irreversible damage to articular cartilage within hours to days, leading to permanent functional disability, chronic joint destruction, or life-threatening systemic sepsis if prompt decompression and antimicrobial therapy are withheld4,6.

1. Etiology & Risk Factors

  • Gram-Positive Pathogens: Staphylococcus aureus (including Methicillin-Resistant S. aureus, MRSA) remains the single most common cause of septic arthritis across all age groups, responsible for over 50% of non-gonococcal cases1,3. Streptococcal species (such as Streptococcus pyogenes and Streptococcus pneumoniae) are also frequent culprits.
  • Gram-Negative Pathogens: Frequently isolated in elderly, debilitated, intravenous drug users, or immunocompromised patients. Common organisms include Pseudomonas aeruginosa and enteric gram-negative bacilli (such as Escherichia coli and Serratia species)2,6.
  • Sexually Transmitted Pathogens: Neisseria gonorrhoeae is the leading cause of septic arthritis in young, sexually active adults, often presenting as a classic triad of tenosynovitis, dermatitis, and migratory polyarthralgia prior to localizing monoarthritis.
  • Host Risk Factors: Pre-existing joint architecture destruction (e.g., rheumatoid arthritis, osteoarthritis, crystal arthropathies), advanced age (>80 years), diabetes mellitus, chronic renal failure, immunosuppressive therapy, intravenous drug abuse, and indwelling vascular catheters or skin ulcers1,6.

2. Pathophysiology

Infection is typically established via hematogenous seeding during transient bacteremia, though direct inoculation from penetrating trauma, animal bites, or contiguous spread from adjacent osteomyelitis and soft tissue infections also occurs4,6. Once bacteria colonize the synovial space, they proliferate rapidly within the nutrient-rich synovial fluid. Bacterial wall components (such as peptidoglycans and lipopolysaccharides) and host-derived cytokines (tumor necrosis factor-alpha, interleukins IL-1 and IL-6) stimulate the massive recruitment of polymorphonuclear neutrophils into the joint cavity. As these neutrophils phagocytose pathogens, they release lysosomal enzymes, reactive oxygen species, and matrix metalloproteinases. Concurrently, chondrocytes are stimulated to produce neutral proteases. This dual enzymatic onslaught rapidly degrades the proteoglycan and collagen matrix of articular cartilage. Elevated intra-articular pressure from purulent effusion compromises microvascular perfusion to the subchondral bone and cartilage, accelerating ischemic necrosis and leading to permanent joint destruction within 48 to 72 hours if drainage is delayed1,6.

Septic arthritis — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Hematogenous seeding or direct inoculation of bacterial pathogens into the synovial cavity 2 Cellular / Pathophysiological Cascade Massive recruitment of polymorphonuclear neutrophils releasing lysosomal enzymes and matrix metalloproteinases 3 Target Organ / Structural Change Rapid enzymatic degradation of hyaline articular cartilage and subchondral bone destruction 4 Hallmark Clinical & Diagnostic Manifestation Severe acute monoarthritis with marked joint effusion, synovial leukocytosis, and systemic inflammation 5 Complications if Untreated & Therapeutic Target Permanent joint destruction or sepsis mitigated via emergent surgical washout and broad-spectrum IV antibiotics

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with an acute, hyper-acute onset (over hours to a few days) of severe, unrelenting joint pain accompanied by profound functional impairment. Constitutional symptoms such as rigors, shaking chills, and documented fever are present in roughly 60% to 80% of adult cases, though they may be absent in elderly or immunosuppressed patients1,6.
  • Physical Examination & Named Clinical Signs: Examination reveals a single warm, visibly swollen, and erythematous joint (monoarthritis in >80–90% of cases; polyarticular involvement suggests gonococcal infection or underlying crystal disease). The joint is held in the position of maximal capsular volume (typically flexion and external rotation) to relieve internal pressure. Any attempt at active or passive range of motion elicits excruciating, agonizing pain, resulting in a complete inability to bear weight or utilize the affected limb. Peri-articular tenderness and regional lymphadenopathy are frequently present. In paediatric populations, the Kocher criteria (history of fever, inability to bear weight, erythrocyte sedimentation rate >40 mm/h, and white blood cell count >12,000/mm³) help differentiate septic hip arthritis from transient synovitis1,5.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationUrgent Synovial Fluid Aspiration (Arthrocentesis): Performed prior to antibiotic administration. Analysis yields cloudy, purulent fluid. Synovial leukocyte count >50,000/mm³ (often 100,000/mm³ or higher) with >90% neutrophil predominance confirms bacterial etiology. Gram stain is positive in ~50–75% of staphylococcal cases and ~25% of gonococcal cases. Cultures (aerobic, anaerobic, and chocolate agar for gonococcus) and polarized light microscopy (to rule out gout/pseudogout crystals) are mandatory1,3.
Laboratory PanelPeripheral white blood cell count is typically elevated (>10,000/mm³ with a left shift), though up to 30% of patients have normal counts. Inflammatory markers are markedly raised: C-reactive protein (CRP) usually >50–100 mg/L and erythrocyte sedimentation rate (ESR) >30 mm/h. Blood cultures (at least two sets) must be drawn prior to starting antimicrobials and are positive in 40–50% of cases1,6.
Imaging / Radiology (X-ray, US, CT, MRI)Plain radiographs serve as a baseline to rule out fractures, chondrocalcinosis, or underlying osteomyelitis, initially showing only soft-tissue swelling and joint space widening. Point-of-care ultrasound (POCUS) or formal US readily detects joint effusions and guides safe aspiration. Magnetic resonance imaging (MRI) with intravenous contrast is the most sensitive modality for early detection of subtle osteomyelitis, soft tissue abscesses, and avascular necrosis.
ECG / Histopathology / ProceduralHistopathological examination of synovial biopsy specimens demonstrates dense neutrophilic infiltration, fibrin deposition, and microvascular thrombosis. Electrocardiography (ECG) is indicated if systemic sepsis precipitates myocardial ischemia or arrhythmias.

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Gächter Classification of Septic Arthritis
  • Stage I: Serous effusion, clear synovial fluid; treatment via arthrocentesis and antibiotics.
  • Stage II: Purulent inflammation, fibrin deposition; urgent arthroscopic or open debridement required.
  • Stage III: Cartilage and bone destruction, phlegmon formation; aggressive surgical washout and prolonged antimicrobials.
  • Stage IV: Panarthrosis, osteomyelitis, joint destruction; salvage procedures or arthrodesis may be necessary.
Kocher Criteria (Paediatric Hip)
  • Inability to bear weight (1 point).
  • Erythrocyte sedimentation rate (ESR) >40 mm/h (1 point).
  • Fever >38.5°C (1 point).
  • Peripheral white blood cell count >12,000/mm³ (1 point).
  • Risk stratification: 1 predictor = 3% risk; 2 predictors = 40% risk; 3 predictors = 93% risk; 4 predictors = 99% risk of septic arthritis.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Crystal Arthropathy (Gout / Pseudogout)Acute monoarthritis mimicking infection. Synovial fluid analysis reveals monosodium urate (needle-shaped, negatively birefringent) or calcium pyrophosphate (rhomboid, positively birefringent) crystals under polarized light. However, crystal arthropathy and infection can occasionally coexist.
Reactive Arthritis (Reiter Syndrome)Sterile inflammatory arthropathy following an enteric or genitourinary infection. Associated with asymmetric oligoarthritis, urethritis, conjunctivitis, and mucocutaneous lesions. Synovial fluid leukocyte counts are generally lower (typically 5,000–50,000/mm³).
HemarthrosisRapid joint swelling following trauma, in patients on anticoagulation therapy, or with underlying bleeding disorders (e.g., hemophilia). Synovial fluid is visibly bloody, and leukocyte counts are low to moderate without purulence.
Osteoarthritis with Acute FlareChronic degenerative joint disease presenting with acute pain and mild effusion due to crystal shedding or mechanical irritation. Synovial fluid is non-inflammatory (<2,000 white blood cells/mm³).

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Assess airway, breathing, and circulation. If signs of severe sepsis or septic shock are present, institute aggressive fluid resuscitation with crystalloids, obtain blood cultures immediately, and initiate broad-spectrum intravenous antimicrobial therapy without waiting for arthrocentesis results1,6.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Empiric coverage for suspected Gram-positive infection (most common): Intravenous Flucloxacillin 2 g IV every 4 to 6 hours (or Cefazolin 2 g IV every 8 hours). In regions or patients with high risk of methicillin-resistant Staphylococcus aureus (MRSA), substitute with Vancomycin 15–20 mg/kg IV every 8 to 12 hours (adjusting for trough serum levels and renal function)1,3.
    • Empiric coverage when Gram-negative bacilli or gonococcal infection is suspected: Add or utilize Ceftriaxone 2 g IV every 24 hours.
    • Duration of Therapy: A total course of 4 to 6 weeks of antimicrobial therapy is standard, transitioning from initial intravenous therapy to high-bioavailability oral agents once clinical improvement and inflammatory marker downward trends are established (typically after 7 to 14 days)1,2,3.
  • Surgical / Interventional Indications: Urgent joint decompression and washout are mandatory. Bedside serial needle aspiration may be adequate for accessible joints (such as the knee) if performed daily and fluid re-accumulation ceases, but operative intervention (arthroscopic or open surgical debridement and washout) is strongly indicated for the hip, joints with loculated purulence, failure to improve within 48 hours of needle aspiration, or concomitant osteomyelitis3,7. Joint immobilization in a functional position should be brief, followed by early active and passive range-of-motion physical therapy to prevent permanent joint contractures.

8. Complications & Prognosis

  • Acute Complications: Sepsis, septic shock, disseminated intravascular coagulation (DIC), deep vein thrombosis, and adjacent osteomyelitis or soft tissue phlegmon1,6.
  • Long-Term Sequelae: Permanent articular cartilage destruction, secondary osteoarthritis, joint ankylosis, osteonecrosis, growth plate arrest in paediatric patients, and chronic disabling pain with reduced range of motion4,5.
  • Prognosis: Mortality rates range from 10% to 15% overall, rising significantly in elderly patients, those with polyarticular involvement, or individuals with pre-existing rheumatoid arthritis. Up to 30% to 50% of survivors suffer permanent functional joint impairment despite timely medical and surgical intervention1,6.